ZA982606B - Agent for preventing and/or treating renal disease - Google Patents

Agent for preventing and/or treating renal disease

Info

Publication number
ZA982606B
ZA982606B ZA982606A ZA982606A ZA982606B ZA 982606 B ZA982606 B ZA 982606B ZA 982606 A ZA982606 A ZA 982606A ZA 982606 A ZA982606 A ZA 982606A ZA 982606 B ZA982606 B ZA 982606B
Authority
ZA
South Africa
Prior art keywords
preventing
agent
renal disease
treating renal
treating
Prior art date
Application number
ZA982606A
Other languages
English (en)
Inventor
Masahiko Kinosaki
Hiromi Ogawa
Hiroaki Masunaga
Fumie Kobayashi
Kyoji Yamaguchi
Kanji Higashio
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of ZA982606B publication Critical patent/ZA982606B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA982606A 1997-03-28 1998-03-27 Agent for preventing and/or treating renal disease ZA982606B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
ZA982606B true ZA982606B (en) 1998-09-30

Family

ID=14125298

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982606A ZA982606B (en) 1997-03-28 1998-03-27 Agent for preventing and/or treating renal disease

Country Status (7)

Country Link
US (1) US6306827B1 (enExample)
EP (1) EP0925791A4 (enExample)
JP (1) JP3961064B2 (enExample)
AU (1) AU734794B2 (enExample)
CA (1) CA2253929A1 (enExample)
WO (1) WO1998043665A1 (enExample)
ZA (1) ZA982606B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531673T2 (de) * 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP4252591B2 (ja) * 2006-08-08 2009-04-08 クロリンエンジニアズ株式会社 オゾン製造装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468400A (en) 1987-09-09 1989-03-14 Sapporo Breweries Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient
JP3380573B2 (ja) * 1992-07-16 2003-02-24 第一製薬株式会社 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
CA2100720C (en) * 1992-07-16 2003-03-11 Hiroaki Masunaga Medicinal composition comprising tcf-ii
DE69531673T2 (de) 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante

Also Published As

Publication number Publication date
JP3961064B2 (ja) 2007-08-15
US6306827B1 (en) 2001-10-23
JPH10273446A (ja) 1998-10-13
AU734794B2 (en) 2001-06-21
EP0925791A4 (en) 2004-06-16
WO1998043665A1 (fr) 1998-10-08
AU6420898A (en) 1998-10-22
EP0925791A1 (en) 1999-06-30
CA2253929A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
GB2342111B (en) Emulsion for well and formation treatment
EP1022945A4 (en) METHOD AND FORMULATION FOR THE TREATMENT OF VASCULAR DISEASES
EP0758234A4 (en) METHOD AND COMPOSITION FOR TREATING NEPHROPATHIES AND RENAL FAILURE
CZ20012113A3 (cs) Prostředky a způsoby pro léčbu onemocnění anorektální oblasti
EP1037635A4 (en) CONNECTIONS AROUND METHODS
ZA985867B (en) Triazole compounds and their use.
GB2326254B (en) Agent system
ZA975338B (en) Malodour preventing agents.
EP0968027A4 (en) VASCULAR ACCESS METHODS AND SYSTEMS
EP1008352A4 (en) Cerebrospinal PROTECTOR
ZA987483B (en) Contrast agent
ZA982606B (en) Agent for preventing and/or treating renal disease
GB2322867B (en) Release agent
EP1117768A4 (en) DNAZYMS AND METHOD FOR TREATING RESTENOSES
GB9826431D0 (en) Fibrous substrayte treatment
PL331283A1 (en) Preparation for treating and/or preventing stupefaction
GB9704174D0 (en) Agent for medical treatment
EP0935965A4 (en) SUBSTANCE AGAINST PYLORI
IL132131A0 (en) Prophylactics and remedies for renal diseases
MD823F1 (en) Antimutagenous agent
ZA984596B (en) Waste treatment system
MD862F1 (en) Remedy for dislipidemy and atherosclerosis treatment
GB9704864D0 (en) Slymgym and super slym
PL302244A1 (en) Feet prespiration preventing agent
GB9703532D0 (en) Anti-microbial agent